Deals, M&A

Sanofi once again extends tender off for Genzyme

Posted on 24 January 2011

Tags: , ,

Sanofi once again has had to extend its $18.5 billion bid for Genzyme. "Sanofi -Aventis and Genzyme are engaged in discussions regarding the structure of a contingent value right involving Lemtrada (alemtuzumab MS) as an element of any potential transaction," the company says in a statement. Read the latest press release from Sanofi, including full contract at Current Agreements

Print Friendly, PDF & Email

Leave a Reply